CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2021$112,000
-1.8%
40,0000.0%0.00%
Q4 2020$114,000
+35.7%
40,0000.0%0.00%
Q3 2020$84,000
-53.8%
40,0000.0%0.00%
Q2 2020$182,000
-50.8%
40,000
-11.6%
0.00%
Q1 2020$370,000
-68.6%
45,230
-29.7%
0.00%
-100.0%
Q4 2019$1,179,000
+56.6%
64,330
-5.4%
0.00%0.0%
Q3 2019$753,000
+15.1%
68,000
+5.8%
0.00%0.0%
Q2 2019$654,000
+73.5%
64,3000.0%0.00%
Q1 2019$377,000
-17.5%
64,3000.0%0.00%
-100.0%
Q4 2018$457,0000.0%64,3000.0%0.00%0.0%
Q3 2018$457,000
+41.5%
64,3000.0%0.00%
Q2 2018$323,000
-54.4%
64,3000.0%0.00%
-100.0%
Q1 2018$708,000
+19.0%
64,3000.0%0.00%0.0%
Q4 2017$595,000
+3.1%
64,3000.0%0.00%0.0%
Q3 2017$577,000
+27.7%
64,3000.0%0.00%0.0%
Q2 2017$452,000
-19.6%
64,3000.0%0.00%0.0%
Q1 2017$562,000
+8.5%
64,3000.0%0.00%0.0%
Q4 2016$518,000
-8.8%
64,3000.0%0.00%0.0%
Q3 2016$568,000
+11.2%
64,3000.0%0.00%0.0%
Q2 2016$511,000
+33.1%
64,3000.0%0.00%0.0%
Q1 2016$384,000
-33.7%
64,3000.0%0.00%0.0%
Q4 2015$579,000
-25.2%
64,3000.0%0.00%0.0%
Q3 2015$774,000
-6.9%
64,3000.0%0.00%0.0%
Q2 2015$831,000
+311.4%
64,3000.0%0.00%
Q1 2015$202,0000.0%64,3000.0%0.00%
Q4 2014$202,00064,3000.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders